Stoke Therapeutics, Inc. · NASDAQ:STOK

FMR LLC reported a 13.60% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 6, 2025

FMR LLC reported a 13.60% stake in Stoke Therapeutics, Inc., 7,412,982 shares, as a passive investor on Jun 30, 2025. Filed Aug 6, 2025 (Schedule 13G/A).

Stake: 13.60%
Shares: 7,412,982
Intent: Passive
What changed: Stake changed
Filed together: 2 holders

The filing in full

Holder	Stake	Shares
FMR LLC	13.60%	7,412,982
Abigail P. Johnson	13.60%	7,412,982

Source

View original at SEC

Related